ロード中...
Naproxen in rheumatoid arthritis. Extended trial.
121 patients with active rheumatoid arthritis, 91 of whom had proved intolerant of other nonsteroidal anti-inflammatory agents, were treated for a mean of 10 months with naproxen. A dosage of 250 mg twice daily produced sustained improvement in most of the standard clinical measurements. 28 patients...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1976
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1006592/ https://ncbi.nlm.nih.gov/pubmed/795386 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|